Guideline-concordant treatment of kawasaki disease with immunoglobulin and aspirin and the incidence of coronary artery aneurysm

Clinical Pediatrics

Volumn 54, Issue 11, 2015, Pages 1076-1080

  Michihata, Nobuaki ^a   Matsui, Hiroki ^a   Fushimi, Kiyohide ^b   Yasunaga, Hideo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

coronary artery aneurysm; epidemiology; guideline concordance; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; NONSTEROID ANTIINFLAMMATORY AGENT;

AGE; ARTICLE; CHILD; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DATA BASE; ECHOCARDIOGRAPHY; FEMALE; GENDER; HOSPITAL PATIENT; HUMAN; IMMUNOTHERAPY; INCIDENCE; INFANT; JAPANESE (PEOPLE); LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEWBORN; PRACTICE GUIDELINE; TREATMENT OUTCOME; COMBINATION DRUG THERAPY; COMORBIDITY; CORONARY ANEURYSM; FACTUAL DATABASE; JAPAN; ODDS RATIO; PRESCHOOL CHILD; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CORONARY ANEURYSM; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; FEMALE; GUIDELINE ADHERENCE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; INFANT; INFANT, NEWBORN; INPATIENTS; JAPAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; ODDS RATIO; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84941557013     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922814566932     Document Type: Article

References (14)

1. Hwang B,. Epidemiology of Kawasaki disease. Pediatr Neonatol. 2014; 55: 78.
2. Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein N, Brogan P,. Management of Kawasaki disease. Arch Dis Child. 2014; 99: 74-83.
3. Newburger JW, Takahashi M, Gerber MA, Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004; 110: 2747-2771.
4. Tsuda E, Hamaoka K, Suzuki H,. A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am Heart J. 2014; 167: 249-258.
5. Ponniah U,. Coronary artery thrombus resulting in sudden cardiac death in an infant with Kawasaki disease and giant coronary artery aneurysms. Ann Pediatr Cardiol. 2013; 6: 197-199.
6. Terai M, Shulman ST,. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr. 1997; 131: 888-893.
7. Jamieson N, Singh-Grewal D,. Kawasaki disease: a clinician"s update. Int J Pediatr. 2013; 2013. Article ID 645391.
8. Research Committee of the Japanese Society of Pediatric Cardiology, Cardiac Surgery Committee for Development of Guidelines for Medical Treatment of Acute Kawasaki Disease. Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version). Pediatr Int. 2014; 56: 135-158.
9. Uematsu H, Hashimoto H, Iwamoto T, Horiguchi H, Yasunaga H,. Impact of guideline-concordant microbiological testing on outcomes of pneumonia. Int J Qual Health Care. 2014; 26: 100-107.
10. McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN,. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med. 2009; 169: 1525-1531.
11. Frei CR, Restrepo MI, Mortensen EM, Burgess DS,. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med. 2006; 119: 865-871.
12. Yasunaga H, Ide H, Imamura T, Ohe K,. Impact of the Japanese diagnosis procedure combination-based payment system on cardiovascular medicine-related costs. Int Heart J. 2005; 46: 855-866.
13. Nakamura Y, Yashiro M, Uehara R,. Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol. 2012; 22: 216-221.
14. Kitano N, Suzuki H, Takeuchi T,. Epidemiologic features and prognostic factors of coronary artery lesions associated with Kawasaki disease based on a 13-year cohort of consecutive cases identified by complete enumeration surveys in Wakayama, Japan. J Epidemiol. 2014; 24: 427-434.